Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Fragai

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|October 20, 2017
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX)Marco Fragai, Giuseppina Comito, Lorenzo Di Cesare Mannelli, et al.
Nucleic Acids Research|August 12, 2025
Deciphering the RNA recognition by Musashi-1 to design protein and RNA variants for in vitro and in vivo applicationsAnna Pérez-Ràfols, Guillermo Pérez-Ropero, Linda Cerofolini, et al.
Nature Communications|September 27, 2024
The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacityPilar Garcia-Vello, Hanne L P Tytgat, Janneke Elzinga, et al.
JACS Au|July 26, 2024
Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal AntibodyPeter T Beernink, Cristina Di Carluccio, Roberta Marchetti, et al.
Computational and Structural Biotechnology Journal|June 29, 2023
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug designGreta Donati, Vincenzo Maria D'Amore, Pasquale Russomanno, et al.
Advanced Drug Delivery Reviews|December 23, 2021
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer modelsGiulia Assoni, Valeria La Pietra, Rosangela Digilio, et al.
Journal of Medicinal Chemistry|January 10, 2018
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR InhibitorsLeonardo Manzoni, Chiara Zucal, Danilo Di Maio, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2023
Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug ConjugatesLinda Cerofolini, Kristian Vasa, Elisa Bianconi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand FlexibilityCristina Di Carluccio, Luis Padilla-Cortés, Marta Tiemblo-Martìn, et al.
European Journal of Pharmacology|February 13, 2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiformeSimona Daniele, Valeria La Pietra, Rebecca Piccarducci, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|October 20, 2017
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX)Marco Fragai, Giuseppina Comito, Lorenzo Di Cesare Mannelli, et al.
Nucleic Acids Research|August 12, 2025
Deciphering the RNA recognition by Musashi-1 to design protein and RNA variants for in vitro and in vivo applicationsAnna Pérez-Ràfols, Guillermo Pérez-Ropero, Linda Cerofolini, et al.
Nature Communications|September 27, 2024
The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacityPilar Garcia-Vello, Hanne L P Tytgat, Janneke Elzinga, et al.
JACS Au|July 26, 2024
Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal AntibodyPeter T Beernink, Cristina Di Carluccio, Roberta Marchetti, et al.
Computational and Structural Biotechnology Journal|June 29, 2023
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug designGreta Donati, Vincenzo Maria D'Amore, Pasquale Russomanno, et al.
Advanced Drug Delivery Reviews|December 23, 2021
HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer modelsGiulia Assoni, Valeria La Pietra, Rosangela Digilio, et al.
Journal of Medicinal Chemistry|January 10, 2018
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR InhibitorsLeonardo Manzoni, Chiara Zucal, Danilo Di Maio, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2023
Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug ConjugatesLinda Cerofolini, Kristian Vasa, Elisa Bianconi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand FlexibilityCristina Di Carluccio, Luis Padilla-Cortés, Marta Tiemblo-Martìn, et al.
European Journal of Pharmacology|February 13, 2021
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiformeSimona Daniele, Valeria La Pietra, Rebecca Piccarducci, et al.
Pageof 16